Cargando…
Up‐regulated deubiquitinase USP4 plays an oncogenic role in melanoma
Melanoma is the most malignant skin cancer with increasing incidence worldwide. Although innovative therapies such as BRAF inhibitor and immune checkpoint inhibitor have gained remarkable advances, metastatic melanoma remains an incurable disease for its notorious aggressiveness. Therefore, further...
Autores principales: | Guo, Weinan, Ma, Jinyuan, Pei, Tianli, Zhao, Tao, Guo, Sen, Yi, Xiuli, Liu, Yu, Wang, Shiyu, Zhu, Guannan, Jian, Zhe, Gao, Tianwen, Li, Chunying, Liao, Wenjun, Shi, Qiong |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2018
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC5908120/ https://www.ncbi.nlm.nih.gov/pubmed/29542252 http://dx.doi.org/10.1111/jcmm.13603 |
Ejemplares similares
-
A20 promotes melanoma progression via the activation of Akt pathway
por: Ma, Jinyuan, et al.
Publicado: (2020) -
POU4F1 promotes the resistance of melanoma to BRAF inhibitors through MEK/ERK pathway activation and MITF up-regulation
por: Liu, Lin, et al.
Publicado: (2020) -
A20 regulates the therapeutic effect of anti-PD-1 immunotherapy in melanoma
por: Guo, Weinan, et al.
Publicado: (2020) -
Ubiquitination in melanoma pathogenesis and treatment
por: Ma, Jinyuan, et al.
Publicado: (2017) -
USP21 deubiquitinase elevates macropinocytosis to enable oncogenic KRAS bypass in pancreatic cancer
por: Hou, Pingping, et al.
Publicado: (2021)